Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

Sponsor
Radboud University Medical Center
Study ID
NCT07686835
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Melanoma
  • Melanoma (Skin Cancer)
  • Melanoma (Skin) Stage IV
  • Melanoma Advanced
  • Melanoma Metastatic

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dried chicory roots — DIETARY_SUPPLEMENT
    The dried chicory roots are implemented using a dosage of 22.5 gram/day resulting in 18.5 gram additional fibers a day.
  • Placebo — DIETARY_SUPPLEMENT
    The control arm will receive 12.4 grams of placebo a day, isocaloric to the intervention.

Study Details

Previous research has shown that a higher fiber intake may have a beneficial effect on the intestinal health and improve the effectiveness of immunotherapy, but this is not certain. The objective of this double-blinded randomized clinical trial is to analyze, whether increased dietary fiber intake by patients with metastatic melanoma will increase the relative amount of Bifidobacterium, which in turn stimulates immune cell activity and improves the response to immunotherapy.

Key Dates

First listed
Jul 7, 2026
Start date
Jun 15, 2026
Status verified
Jun 2026
Primary completion
May 1, 2028
Completion
Apr 30, 2029

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Fiber intervention arm
    Dried chicory roots
  • Placebo Comparator: Placebo arm
    iso-caloric placebo (rice-puffs)

Primary Outcome Measure

An increase in the relative abundance of Bifidobacterium in fecal samples. [ Time Frame: From baseline (T0) to 3-4 weeks (T1) after start ICI ]

Central Contacts

Find similar trials

Nationwide
Melanoma trialsOncology trialsSkin cancer trialsDermatology trials

Related Studies